Rona Therapeutics
PrivateLast Round
VC Round
Mar 16, 2025
Total Funding Raised
$68M
Company Overview
Rona Therapeutics operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a VC Round in March 2025.
Rona Therapeutics is a biotechnology company that develops an RNA therapeutics platform designed for RNA medicine discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rona Therapeutics Comparables
Compare Rona Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Argo Biopharma | 89% | |
| Visirna Therapeutics | 88% | |
| Sirius Therapeutics, Inc. | 86% |
For institutional investors. Book with your work email.
Rona Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 16, 2025 | ||||
| Series A Extension | Jul 19, 2024 | ||||
| Series A | Apr 7, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Rona Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longriver Investment Partners | Series A Extension |
| BioTrack Capital | VC Round, Series A Extension |
| 招银国际金融有限公司 | Series A |
| Guanghua Wutong Fund | VC Round |
| Lapam Capital | Series A, Series A Extension |
| Platanus Ventures | Series A |
| LongRiver Investments | VC Round, Series A Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Monthly visitors grew 117% MoM, reaching 3.6K.
- Jan 6, 2026
Monthly visitors increased 2227% MoM, reaching 7.5K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withOct 13, 2026
On Oct 13th '26, Rona Therapeutics, Inc partners with Roche to develop and commercialize an ALK7-targeting RNAi therapy for obesity and metabolic diseases, combining extrahepatic RNAi R&D with global development and commercialization expertise; the agreement provides Rona Therapeutics, Inc with up to $100M in upfront and near-term milestone payments, up to $1.06B in potential development, regulatory and commercial milestones, and tiered royalties on global net sales.
- licenses_technologyOct 13, 2026
On Oct 13th '26 in California, Rona Therapeutics, Inc grants Roche an exclusive worldwide license for its investigational RNAi candidate targeting ALK7 through its proprietary extrahepatic delivery platform.
For institutional investors. Book with your work email.
Rona Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rona Therapeutics's valuation, stock price, and market status.
Is Rona Therapeutics a public or private company?
Rona Therapeutics is a private company.
What is the current stock price of Rona Therapeutics?
Rona Therapeutics is a private company, so its shares have no public market price. Caplight tracks Rona Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rona Therapeutics worth (valuation)?
Valuation information for Rona Therapeutics is not publicly available.
Can I buy Rona Therapeutics stock?
Rona Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rona Therapeutics's last funding round?
Rona Therapeutics's most recent funding round was VC Round on March 16, 2025.
Who are the main investors in Rona Therapeutics?
Key investors in Rona Therapeutics include Longriver Investment Partners, Guanghua Wutong Fund, LongRiver Investments.
Will Rona Therapeutics IPO soon?
No public IPO plans have been announced for Rona Therapeutics.
How can I track Rona Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Rona Therapeutics's shares on secondary markets.